cetirizine has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobo Calvo, A | 1 |
| Albertí Aguiló, MA | 1 |
| Casasnovas Pons, C | 1 |
1 other study available for cetirizine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Myasthenia gravis exacerbation after cetirizine administration.
Topics: Cetirizine; Disease Progression; Female; Humans; Myasthenia Gravis; Young Adult | 2011 |